The CEO of pharmaceutical company AstraZeneca said Thursday that the coronavirus vaccine that the company is testing could still be ready by the end of the year, despite the fact that the company paused the clinical trials of the medicine after a test subject got sick.
As previously reported by The Inquisitr, AstraZeneca is one of multiple drug manufacturers working on getting a vaccine against SARS-CoV-2, the pathogen responsible for the COVID-19 pandemic, as soon as possible, despite the fact that the process normally takes years. The Cambridge, England-based manufacturer has been conducting large-scale clinical trials, involving thousands of volunteers, on the so-called “Oxford Vaccine,” developed in conjunction with a team from the British university, that so far appears to be one of the best candidates for a safe and effective immunization.
0 comments :
Post a Comment